SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000912057-99-003957
Filing Date
1999-11-08
Accepted
1999-11-08 00:00:00
Documents
3
Group Members
BIOTECHNOLOGY VALUE FUND L PBVF INC.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A SC 13D/A 13309
2 EXHIBIT 99.1 EX-99.1 1591
3 EXHIBIT 99.2 EX-99.2 1608
  Complete submission text file 0000912057-99-003957.txt   18774
Mailing Address 128 SPRING STREET LEXINGTON MA 02173
Business Address 128 SPRING ST LEXINGTON MA 02173 6178600710
AUTOIMMUNE INC (Subject) CIK: 0000879106 (see all company filings)

IRS No.: 133489062 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-44757 | Film No.: 99743568
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice